XML 41 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jul. 31, 2020
Apr. 30, 2020
Current Assets:    
Cash and cash equivalents $ 3,990 $ 4,365
Restricted cash 835 850
Receivables, less allowance; $612; $606, on each respective date 30,897 28,062
Inventories 16,458 15,330
Prepaid expenses and other current assets 6,298 5,624
Total Current Assets 58,478 54,231
Property, plant and equipment, at cost 58,818 57,859
Accumulated depreciation (42,310) (41,587)
Net Property, Plant and Equipment 16,508 16,272
Right of use assets 8,828 9,312
Deferred income taxes 330 336
Other assets 3,034 3,778
Total Assets 87,178 83,929
Current Liabilities:    
Short-term borrowings 8,524 4,719
Current portion of capital lease liability 20 19
Current portion of operating lease liabilities 1,256 1,282
Accounts payable 14,091 13,114
Employee compensation and amounts withheld 4,001 4,159
Deferred revenue 1,432 2,508
Other accrued expenses 1,336 1,259
Total Current Liabilities 30,660 27,060
Long-term portion of capital lease liability 108 113
Long-term portion of operating lease liabilities 7,471 7,780
Accrued pension and deferred compensation costs 9,654 9,303
Deferred Income Tax Liabilities, Net 369 401
Other non-current liabilities 735 569
Total Liabilities 48,997 45,226
Commitments and Contingencies
Stockholders’ Equity:    
Common stock, $2.50 par value, Authorized – 5,000 shares; Issued – 2,762 shares; 2,754 shares; – Outstanding – 2,759 shares; 2,751 shares, on each respective date 6,905 6,885
Additional paid-in-capital 3,438 3,360
Retained earnings 37,223 37,821
Accumulated other comprehensive loss (9,611) (9,598)
Common stock in treasury, at cost, 3 shares, on each date (53) (53)
Total Kewaunee Scientific Corporation Stockholders’ Equity 37,902 38,415
Noncontrolling interest 279 288
Total Stockholders’ Equity 38,181 38,703
Total Liabilities and Stockholders’ Equity $ 87,178 $ 83,929